Please provide your email address to receive an email when new articles are posted on . In high-risk patients with a prior MI and cardiac autonomic dysfunction, use of an implantable cardiac monitor ...
BERLIN, July 28, 2021 /PRNewswire/ -- In association with Heart Rhythm 2021, BIOTRONIK today announced that the latest implantable cardiac monitor (ICM), BIOMONITOR IIIm, has been recognized by ...
Remote monitoring of patients with implantable cardiac devices reduced the mortality rate for cardiac patients by 50 percent and improved their clinical status by nearly 10 percent in a randomized ...
- The global implantable cardiac monitor market is expected to expand as the occurrence of cardiac arrhythmias like bradycardia and atrial fibrillation surges - The demand is implantable cardiac ...
Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was ...
Abbott's implantable cardiac sensor system CardioMEMS landed an expanded FDA clearance, allowing earlier stage heart failure patients to use the tech. The system, which is designed to monitor pressure ...
Please provide your email address to receive an email when new articles are posted on . Angel Medical Systems announced its second-generation implantable cardiac detection monitor, which can warn ...
LAKE OSWEGO, Ore., June 12, 2023 /PRNewswire/ -- BIOTRONIK, a leader in implantable medical device technology, today announced the first global implantation of its BIOMONITOR IV implantable cardiac ...
Sophia Antipolis, France – 27 Aug 2021: Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of serious arrhythmias in high-risk post-infarction patients ...
Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was ...
Implantable cardiac monitors (ICMs) continuously monitor the patient's electrocardiogram and perform real-time analysis of the heart rhythm, for up to 36 months. The current clinical use of ICMs ...
Introduction: Management of congestive heart failure is a serious public health problem. The use of implantable hemodynamic monitors (IHMs) may assist in this management by providing continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results